Open original FDA record ↗Recall record
- FDA identifier
- Z-1911-2008
- Company in FDA record
- Philips Medical Systems
- FDA classification date
- Sep 16, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Some users of SureSigns VS3 Signs Monitor may have assumed that the SpO2 Non-Pulsatile and SpO2 No Sensor technical alarms were enabled when the SureSigns VS3 Vital Signs Monitor was not in Interval non-invasive blood pressure (NBP) mode. These alarms are only enabled when interval NBP mode is selected. If when monitoring SpO2, the clinician does not notice when the sensor is no longer attached, the patient is not being monitored through Spo2.This could result in delay or lack of needed therapy. The labeling provided with the monitor did not fully describe this feature.
Source facts
- Action
- All affected customers will receive the FSN (Field Safety Notice )informing them about the labeling correction. Included with the FSN will be an addendum to the instructions for use. customers are asked to read the addendum and insert a copy into each of their copies of the VS3 instructions for use. Customers will also receive a Medical Device Correction Confirmation Card that they will be asked to fill out and fax back to their local Philips representative. Contact your local Philips support organization at 1-800-722-9377 in the United States or 1-800-323-2280 in Canada.
- Initiated
- 2008-04-30
- Root cause
- Labeling design
- Terminated
- 2017-03-29
- Distribution
- Worldwide Distribution to United States, Canada and Foreign countries
- Recall number
- Z-1911-2008
- Recall status
- Terminated
- CDRH record ID
- 70436
- FDA classified
- 2008-09-16
- Recall event number
- 47886